Xudong N. Gao
No. 30 Xueyuan Road
Haidian, China
Haidian, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Serum biomarker analysis may guide management of anemia in patients with chronic liver disease.
Journal: Frontiers in medicine
Published: January 28, 2026
Pharmacokinetics, distribution, metabolism, excretion and safety characterization of ZJCK-6-72: novel DYRK1A inhibitor with optimized brain exposure for Alzheimer's disease therapy.
Journal: Frontiers in pharmacology
Published: January 20, 2026
ZRMQ-22, a novel DYRK1A inhibitor, attenuates neuroinflammation and cognitive impairments in LPS-induced mice: a potential strategy for Alzheimer's disease.
Journal: RSC medicinal chemistry
Published: January 05, 2026
Link Prediction of Green Patent Cooperation Network Based on Multidimensional Features.
Journal: Entropy (Basel, Switzerland)
Published: December 17, 2025
Transarterial Chemoembolization Combined with Regorafenib and PD-1 Inhibitor as Second-Line Therapy for Unresectable Hepatocellular Carcinoma.
Journal: Cancer management and research
Published: November 17, 2025
Fluorocyclopropyl-Containing Tacrine Derivatives as Potent and Selective Dual CDK2/CDK9 Inhibitors for the Treatment of Colorectal Cancer.
Journal: Journal of medicinal chemistry
Published: November 15, 2025
Cloud Model-Based Adaptive Time-Series Information Granulation Algorithm and Its Similarity Measurement.
Journal: Entropy (Basel, Switzerland)
Published: December 04, 2024
Discovery of ZJCK-6-46: A Potent, Selective, and Orally Available Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor for the Treatment of Alzheimer's Disease.
Journal: Journal of medicinal chemistry
Published: July 23, 2024
The ADAM17 inhibitor ZLDI-8 sensitized hepatocellular carcinoma cells to sorafenib through Notch1-integrin β-talk.
Journal: Pharmacological research
Published: October 25, 2023
Discovery of novel harmine derivatives as GSK-3β/DYRK1A dual inhibitors for Alzheimer's disease treatment.
Journal: Archiv der Pharmazie
Published: July 26, 2023
Last Updated: 09/26/2026